FibroScan FAQ: Your questions answered

Written in association with: Professor Patrick Kennedy
Published:
Edited by: Conor Dunworth

FibroScan is a tool used to offer instant insight into a patient’s liver health. In his latest online article, esteemed consultant hepatologist Professor Patrick Kennedy answers your most commonly asked questions about this new tool.

 

What is FibroScan and what is it used for?

FibroScan is a non-invasive tool used to measure liver damage in the clinic. At this point, I would consider it an integral part of our investigation and management of patients because it is such an easy test to undertake during a clinic visit. With FibroScan, we can obtain results instantaneously and provide them to the patient. This tool informs us about fibrosis, the degree of liver fibrosis, and the degree of fat within the liver. Previously, we would have had to rely on a liver biopsy for this information, which is an invasive test. FibroScan is a simple non-invasive tool that provides immediate results in the clinic, aiding in better understanding liver disease and making management decisions.

 

How is a FibroScan performed?

FibroScan is performed in the clinic after a patient fasts for some time. They will then attend the clinic and be seen in the examination room. The procedure is similar to a simple ultrasound scan, but FibroScan generates a shear wave, and we measure the return speed of that shear wave, which indicates the stiffness of the liver. The higher the value, the stiffer and more fibrotic the liver, indicating more damage. These results are conveyed to patients in a specific readout, indicating the severity of fibrosis and even cirrhosis.

 

Who may need to undergo this type of scan?

FibroScan is a simple, non-invasive test that provides immediate results, making it an integral part of diagnosing and managing liver disease. Anyone with abnormal liver tests or suspected chronic liver disease or damage can undergo this test. It provides valuable information to both the treating physician and the patient about the degree of liver damage and the amount of fat in the liver.

 

How can patients prepare for a FibroScan?

There is minimal preparation required for a FibroScan, apart from fasting for a minimum of three to four hours before the test. Unlike liver enzymes, FibroScan measurements of scarring, fibrosis, stiffness, and fat do not fluctuate rapidly. Thus, fasting is the only preparation needed before the test.

 

What are the next steps after a patient undergoes a FibroScan?

After undergoing a FibroScan, both the patient and the clinician immediately know the extent of liver damage. This information is crucial for the patient's peace of mind and guides further investigations and management. If the scan indicates no liver fibrosis, it reassures the patient and allows for timely management decisions. Conversely, if significant liver damage is detected, it expedites further investigations and directs the management plan without delay. The immediate results of FibroScan enable prompt decision-making, reassurance, and appropriate management, sometimes even leading to the discharge of patients from the clinic.

 

 

Professor Patrick Kennedy is a renowned consultant hepatologist based in London. If you would like to book a consultation with Professor Kennedy, you can do so today via his Top Doctors profile.

By Professor Patrick Kennedy
Hepatology (liver specialist)

Professor Patrick Kennedy is a leading London-based consultant physician and hepatologist, whose work in viral liver disease is known internationally.
 
Professor Kennedy trained at University College Dublin. Upon completion of his initial medical training, he undertook post-graduate training in London and was subsequently appointed as a senior lecturer at Barts and The London School of Medicine and Dentistry in 2009.

Professor Kennedy  has a special interest in the management of liver disease in young people, working closely with premiership football clubs and managing liver disease in professional sports people and elite athletes from the UK and abroad.
 
He has produced novel work redefining disease phase in chronic hepatitis B (CHB). The main focus of his curent research work is around broadening treatment candidacy and the development of individualised treatment strategies for viral liver disease. He is widely published in the field of hepatology, with over 200 publications and 90 peer-reviewed articles, in addition to multiple book chapters, he has also edited a textbook of hepato-gastroenterology.
 
Additionally, Professor Kennedy is an expert advisor for the WHO and is part of the HBV clinical guideline development group. He is also a member of the European Association for the study of the liver (EASL) HBV clinical practice guidelines and has served as a member for NICE on the viral hepatitis clinical guideline committee.
 
Furthermore, Professor Kennedy provides expert opinion for the United Kingdom Advisory Panel (UKAP) on blood-borne viruses and is the current chair of the British Viral Hepatitis Group and former Lead for the British Association for the Study of the Liver (BASL) HBV special interest group. He works closely with industry and provides expert opinion on drug development programmes.
 
He is the principal Investigator for a number of investigator-led and commercial phase 1, 2 and 3, clinical trials of novel therapies in viral liver disease. At present, he leads studies on the development of novel therapies in HBV and hepatitis delta virus (HDV). In addition, he is passionate about patient education and ensuring patients play a central role in their own management. Professor Kennedy has developed HBV&Me, a management app, and a current area of his research is expanding the utility of patient management tools to improve care.

View Profile

Overall assessment of their patients


  • Related procedures
  • Gastroscopy
    Endoscopy
    Colonoscopy
    Fatty liver
    Gallstones
    Liver surgery
    Jaundice
    Abdominal pain
    Cirrhosis
    Liver biopsy
    This website uses our own and third-party Cookies to compile information with the aim of improving our services, to show you advertising related to your preferences as well analysing your browsing habits. You can change your settings HERE.